Table 1 Main patients’ characteristics according to 28-day mortality
All patients (151) | Non-survivors (68) | Survivors (83) | p | |
|---|---|---|---|---|
Gender, n (%) | 98 (64.9) | 47 (69.11) | 51 (61.45) | 0.42 |
Age_median (IQR) | 69 (62–80) | 72 (64–79) | 67 (60 -80) | 0.11 |
Severity Score at Admission_median (IQR) | ||||
SOFA | 10 (8–13) | 12 (9–14) | 9 (7–12) | < 0.0001 |
SAPS II | 65 (53.75–79.25) | 73 (63–86) | 59 (46–69) | 0.002 |
Charlson | 2 (1–4) | 3 (2- 5) | 1 (0 -3) | < 0.0001 |
Exposure to Invasive device (Day_ median (IQR) | ||||
Tracheal Intubation | 3 (1 -9) | 3 (1–9.5) | 3 (0–7) | 0.16 |
Venous Catheter | 6 (3–13) | 4 (2- 12) | 7(5–17) | 0.002 |
Urinary Catheter | 6 (2–11.7) | 4 (1–9) | 6 (4–13) | 0.006 |
Primary site of infection, n (%) | ||||
Respiratory | 31 (20.5) | 22 (32.4) | 9 (10.8) | 0.019 |
Intra abdominal | 69 (46) | 26 (38.2) | 43 (51.8) | 0.009 |
Urinary | 15 (10) | 3 (4.4) | 12 (14.4) | 0.020 |
Diagnosis Microbiologicaly confirmed, n (%) | 108 (71.5) | 45(66.2) | 63 (75.9) | 0.083 |
Nosocomial Infection, n (%) | 26 (17.2) | 9 (13) | 17 (20) | 0.12 |
ICU length of Stay | 7 (4 -16) | 4.5 (2–13) | 9 (6 -20) | < 0.0001 |